Asceneuron
PrivateLast Round
Series C
Jul 16, 2024
Total Funding Raised
$139.53M
Company Overview
Asceneuron is a biotechnology company that develops orally bioavailable therapeutics for neurodegenerative disorders such as Alzheimer's, Parkinson's, and orphan tauopathies.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Asceneuron Comparables
Compare Asceneuron with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Treventis Corporation | 84% | |
| Alectos Therapeutics | 84% | |
| Oligomerix, Inc. | 83% | |
Asceneuron Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Jul 16, 2024 | ||||
| Grant | Mar 9, 2021 | ||||
| Series A | Sep 29, 2015 | ||||
| Grant | Apr 14, 2015 | ||||
| Seed | Oct 2, 2012 |
Asceneuron Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series C |
| OrbiMed | Series C |
| Novo Holdings | Series C |
| Sofinnova Partners | Series C, Series A |
| SR One | Series A, Series C |
| Johnson & Johnson Innovation - JJDC, Inc. | Series A, Series C |
| M Ventures | Series A, Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 16, 2024
$100M round led by Novo Holdings.
- Sep 29, 2015
$31M round led by Sofinnova Partners.
Asceneuron Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Asceneuron's valuation, stock price, and market status.